ClinicalTrials.gg
RecruitingNCT06705790Updated May 8, 2026

Exploring the Benefits of Pelvic Floor Muscle Training on Bladder, Bowel, and Sexual Function in People With Spinal Cord Injury

An interventional study of Pelvic Floor Muscle Training in Spinal Cord Injury, sponsored by University of British Columbia. Recruiting at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
19 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 44 studies in Spinal Cord Injuries by University of British Columbia — 16 open to participants now, 18 under way, none of them phase 3. Spinal Cord Injuries · University of British Columbia.

Planned enrollment
13th of 38
30 · median 22
Started
2026
with 4 others
No phase
31 of 44
13 open now
Primary completion
2028-03
later than 13 of 17 live
Registered
37th of 44
by date

Among the 44 studies in Spinal Cord Injuries by University of British Columbia, this one is the 13th largest by planned enrollment of the 38 interventional ones that give a count, is one of 5 that started in 2026, is one of 31 with no phase, reaches primary completion later than 13 of the 17 other live ones, and was the 37th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

16 of the 44 studies in Spinal Cord Injuries by University of British Columbia are open now, in 2 countries. Recruiting first, the newest first:

10 more — sign in →

By country, each count listing its studies:

All 16 open studies →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 19 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Spinal Cord Injuries by University of British Columbia, or all of them as a file.
02

Study summary

The goal of this trial is to learn about the feasibility and benefits of delivering a pelvic floor muscle training program to people with motor-incomplete spinal cord injury. The main questions it aims to answer are:

  1. To evaluate the feasibility of delivering a pelvic floor muscle training program to people with spinal cord injury. The investigators will examine recruitment rate, compliance and adherence to the intervention and other study protocols, adverse events, and participant perspectives of the study protocols.
  2. To explore the potential effectiveness of pelvic floor muscle training on pelvic floor, bladder, bowel, and sexual function.

Participants will be asked to complete a pelvic floor muscle training program for 3 months. At the beginning, middle, and end of the program, researchers will conduct a series of tests to determine the feasibility and potential effectiveness of this program.

03

Conditions studied

  • Spinal Cord Injury

Keywords

  • Spinal Cord Injury
  • Pelvic Floor Muscle Training
  • Bladder
  • Bowel
  • Sexual Health
04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Are at least 19 years of age.
  • Have a non-progressive, motor-incomplete spinal cord injury that is at or above the T12 neurological level at least 12 months ago.
  • Have symptoms of bladder, bowel, and/or sexual dysfunction that are caused by your spinal cord injury.
  • Have stable management of spinal cord related secondary health concerns (e.g., spasticity, neuropathic pain).
  • Are able to speak and understand English.

Exclusion criteria

Exclusion Criteria:

  • Are currently pregnant, have been pregnant within the past 6 months, or are planning to become pregnant in the next 6 months.
  • Have had urogenital surgery within the past 12 months.
  • Have received Botox bladder injections within the past 4 weeks, or anticipate receiving an injection in the next 6 months.
  • Have presence of severe medical issue that in the investigator's judgement would adversely affect the participant's participation in the study. Examples include, but are not limited to pressure sores, cardiovascular disease, and unmanaged diabetes.
  • Have any permanent metal fixtures in their head (excluding dental fillings), or pacemakers, stimulators, or implanted medication pumps.
  • Have a history of seizures, are taking medications that lower the seizure threshold, or experience recurring headaches.
  • Have a condition for which exercise is .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Pelvic Floor Muscle Training Group

    Behavioral: Pelvic Floor Muscle Training

Interventions

  • BehavioralPelvic Floor Muscle Training

    Pelvic floor muscle training 5x/week for 12-weeks

06

What researchers measure

Primary outcomes

  1. Feasibility - Recruitment Rate

    Recruitment rate will be evaluated by number of participants approached, screened for eligibility, as well as reasons for exclusions.

    Time frame: Through study completion, up to 12 weeks

  2. Feasibility - Compliance

    Compliance will be tracked by the adherence of participants to the prescribed exercise program, with reasons for missed sessions or drop-outs noted.

    Time frame: Through study completion, up to 12 weeks

  3. Feasibility - Adverse Events

    Any adverse events to study protocols will be recorded.

    Time frame: Through study completion, up to 12 weeks

  4. Feasibility - Acceptability

    The acceptability of the intervention will be evaluated using a 7-point Likert scale to rate participants' enjoyment of the exercise program and whether they felt the program was beneficial for improving their bladder, bowel, and/or sexual function.

    Time frame: Through study completion, up to 12 weeks

Secondary outcomes

  1. Incontinence Quality of Life Questionnaire (I-QoL)

    Participants will be asked to respond to 22 questions about how urinary incontinence impacts their quality of life using a 5-point scale with values ranging from 1 (extremely) to 5 (not at all). The questionnaire probes three subdomains of how incontinence may affect quality of life: avoidance and limiting behavior, psychosocial impact, and social embarrassment.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  2. Neurogenic Bladder Symptoms Score (NBSS)

    Participants will be asked to respond to 24 questions regarding the severity of their bladder symptoms secondary to neurological injury. Questions cover three subdomains: incontinence, storage and voiding, and consequences.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  3. 3-Day Bladder Diary

    Participants will be asked to record information regarding their fluid intake (i.e., time, volume, and type) and voids (i.e., time, volume, leaks, and pad change) for three days. The investigators will use the combined information on intake and voids to make a clinical summary of the participants urinary function.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  4. Timed Bowel Movement

    Participants will be asked to how long their bowel movements take, and what (if any) aids they used to complete the bowel movement (e.g. suppository, laxatives, digital stimulation/evacuation, etc).

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  5. Neurogenic Bowel Dysfunction Score (NBDS)

    Participants will be asked to complete the NBDS which asks 11 questions to clinically assess the severity of their bowel dysfunction symptoms. Results of this questionnaire provide a score from 0 to 47, where a higher score represents more severe bowel symptoms.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  6. International Index of Erectile Function (IIEF) Questionnaire (Males only)

    Male participants will be asked to complete the IIEF questionnaire which askes 15 questions to clinically assess sexual health in 5 domains: erectile function (possible score of 0-30), orgasmic function (possible score of 0-10), sexual desire (possible score of 0-10), intercourse satisfaction (possible score of 0-15), overall satisfaction (possible score of 0-10). In all domains, a higher score represents more severe sexual dysfunction.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  7. Female Sexual Function Index (FSFI) Questionnaire (Females Only)

    Female participants will be asked to complete the FSFI questionnaire which askes 19 questions to clinically assess sexual health in 6 domains: desire (possible score of 1.2-6), arousal (possible score of 0-6), lubrication (possible score of 0-6), orgasm (possible score of 0-6), satisfaction (possible score of 0.8-6), and pain (possible score of 0-6). In all domains, a higher score represents a less sexual dysfunction.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  8. Sexual Quality of Life Questionnaire - Male/Female

    Male and female participants will both be asked to complete their sex-specific version of this questionnaire. This questionnaire asks respondents to rate 11 statements (male, possible score of 11-66) or 18 statements (female, possible score of 18-108) according to how much they agree or disagree with it. For both the male and female version of the questionnaire, a higher score represents better sexual quality of life.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  9. Pelvic Floor Electromyography

    PFM function (i.e., endurance and motor control) will be assessed using surface electromyography (EMG). Disposable surface electrodes will be placed perianally to record from the pelvic floor muscles, and other electrodes will be placed over the relevant muscles in the trunk and legs. Participants will be asked to attempt various contractions of their pelvic floor muscles including a maximal, isolated pelvic floor contraction; a sustained pelvic floor contraction to assess endurance; and a rapid contract-relaxation task to assess motor control.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  10. Effectiveness of Cueing

    Researchers will ask participants about their perceived effectiveness of verbal instructions and feedback strategies used in the pelvic floor muscle training sessions for facilitating voluntary activation of the pelvic floor.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  11. Transcranial Magnetic Stimulation (TMS) Assessment

    The investigators will assess the connection of the neural pathways between the brain and pelvic floor using transcranial magnetic stimulation (TMS). TMS will be delivered over the primary motor cortex in the brain, and motor evoked potentials (MEPs) will be recorded using surface electromyography from the pelvic floor. Participants will be instruction to maintain a sub-maximal contraction of the pelvic floor during the experiment, while TMS pulses are delivered at a variety of intensities.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  12. Pudendal Somatosensory Evoked Potential (SEP) Assessment

    Pudendal nerve function will be assessed through an somatosensory evoked potential (SEP) assessment. Non-painful electrical stimulations of up to 1ms in duration will be delivered to the pudendal nerve via the electrodes placed over the genitals while the investigators simultaneously use an electroencephalography (EEG) cap to record from the somatosensory cortex.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

  13. Transperineal Ultrasound

    Pelvic floor muscle function will be assessed through transperineal ultrasound. An ultrasound probe will be placed on the perineum to visualize the pelvic floor and other relevant pelvic structures (e.g. bladder, urethra, vaginal canal, sphincters, pelvic bones). Ultrasound images and recordings will be taken while the participant is at rest and as they attempt PFM contractions.

    Time frame: From enrollment to within 2 weeks of completing the study intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Mar 2028, 21 months later.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 21 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 18, 2024
First posted
Nov 26, 2024
StartEst.
Jun 1, 2026
Primary completionEst.
Mar 31, 2028
CompletionEst.
Mar 31, 2028
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06705790
Responsible party
Tania Lam (Principal Investigator, University of British Columbia) — Principal investigator
First posted
Nov 26, 2024
Start date
Jun 1, 2026 (estimated)
Primary completion
Mar 31, 2028 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
May 8, 2026

Study contacts

Alison Williams
Contact
alison.williams@ubc.ca
604-675-8815
Tania Lam, PhD, PT
principal investigator · University of British Columbia, ICORD

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion